Programme Committee Members

View the group of Hepatitis experts who contributed their valuable insights and helped shape the WHS 2024 programme.
DANJUMA

Danjuma Adda

WHS 2024 Committee Co-Chair
WHA Past President

Meg Doherty

Meg Doherty

WHS 2024 Committee Co-Chair
Director Global HIV, Hepatitis and STI Programmes
World Health Organization

Ricardo Baptista Leite

Ricardo Baptista Leite

President of the Board
UNITE Parliamentarians Network for Global Health

MARIA BUTI

Maria Buti

Professor of Medicine Hospital Universitario VAlle Hebron
EASL Public Health Councilor

Chari Cohen

Chari Cohen

President
Hepatitis B Foundation

Filler profile image

Erika Duffell

European Centre for Disease Prevention and Control (ECDC)

Filler profile image

Philippa Easterbrook

Global Hepatitis Programme
World Health Organization

Oriel Fernandes

Oriel Fernandes

Senior Director, Viral Hepatitis
Clinton Health Access Initiative

Ricardo Fuertes

Ricardo Fuertes

Advisor for the Secretary of State of Health Promotion
Ministry of Health, Portugal

Kimberly Green

Kimberly Green

Global Program Director, Primary Health Care
PATH

Dr Hailemichael Desalegn Mekonnen MD, PhD

Dr Hailemichael Desalegn Mekonnen MD, PhD

Associate Professor of Medicine: Consultant Internist, Gastroenterologist/Hepatologist
St. Paul's Hospital Millennium Medical College

Rachel Halford

Rachel Halford

WHA President

Saeed Hamid

Saeed Hamid

Professor of Medicine, Consultant Gastroenterologist, Director Clinical Trials Unit
Aga Khan University, Karachi, Pakistan

Jessica Hicks

Jessica Hicks

WHA Director

Cary James

Cary James

WHA CEO

Giten Khwairakpam

Giten Khwairakpam

Program Manager
TREAT Asia/amfAR

Funmi Lesi

Funmi Lesi

Global HIV, Hepatitis and STIs Programmes Lead
World Health Organization

Dr Niklas Luhmann

Niklas Luhmann

Technical Officer
Testing, prevention and populations team
World Health Organization

Luís Mendão

Luís Mendão

Advocacy, Health Policies and External Relations Director
GAT Portugal

Filler profile image

Marcelo Naveira

Medical Officer
WHO Regional Office for Europe

Homie Square

Homie Razavi

Managing Director
Center for Disease Analysis Foundation

Daniel Simões

Daniel Simões

Strategic Information Manager
Coalition PLUS

Rui Tato Marinho

Rui Tato Marinho MD, PhD

Gastroenterologist and Hepatologist
President of National Program for Viral Hepatitis for the Directorate General of Health, Ministry of Health

JohnWard4242compress

Dr John Ward

Director, Coalition for Global Hepatitis Elimination (CGHE)

Ernst WISSE

Ernst WISSE

Harm Reduction Advisor
Médecins du Monde - France

Hepatitis and PWID/harm reduction 

 

11:35 – 11:40  

Chair: WHO – Intro and set the scene.  

 

11:40 – 11:55  

Co-chair:  EMCDDA – Monitoring viral hepatitis elimination among PWID in Europe. 

 

11:55 – 12:00 

ID 29: Ema Pos (not yet registered) 

Title: If the mountain won’t come to Mohammed: lessons from a decentralized Infectious Disease consultation. 

 

12:05 – 12:10  

ID 152: Brian Conway (Registered in person) 

Title: Community Pop-up Clinic: Cascade of Care and HCV Treatment of Vancouver’s inner-city PWID Populations.

 

12:10 – 12:15 

ID 212: Jasmine West (not yet registered) 

Title: From lived experience to lived expertise: a syndemic approach. 

 

12:15 – 12:20 

ID: 299 Mercy Nyakowa (Registered in person) 

Title: HCV and HBV prevalence and associated risk factors among people who inject drugs (PWIDs) in Kenya 

 

12:20 – 12:25 

ID: 133 Nalinikanta Rajkumar (Registered in person) 

Title: Rapid regimen of HBV vaccination: Does it work for high risk groups?  

 

12:25 – 12:30 

Q&A and closing remarks   

The role of decentralised and community-led services in accelerating progress towards elimination.

Role of harm reduction.